It would seem that the time when machines surpass the ability of humans to do intricate work is almost here. One of Google’s Artificial Intelligence projects is apparently capable of diagnosing the retina of patients to see if they are about to go blind. The search engine company even went so far as to claim that the AI is better than actual doctors at diagnosis.
As Google noted in a blog post about the AI, Diabetic retinopathy is a quickly rising cause of blindness among patients in the world. The disease is treatable, but only if it is caught early enough to respond to treatments. This is where effective diagnosis comes into play.
“Unfortunately, medical specialists capable of detecting the disease are not available in many parts of the world where diabetes is prevalent,” the blog post reads. “We believe that Machine Learning can help doctors identify patients in need, particularly among underserved populations.”
The findings with regards to the diagnostic capabilities of the AI was published in the Journal of the American Medical Association. The paper included proposals on certain potential benefits that machine learning could provide with regards to diagnosing medical problems and even helping to find ways to treat them.
In the case of blindness caused by Diabetic retinopathy, the AI is fed images of retinas, which it will then scan and analyze for any of the telltale sign of impending blindness. After going through 128,000 images of retinas with the traits that led to the condition, the AI was given 10,000 new images to diagnose. Based on the results, the machine was much better at detecting which images posed the biggest threat of blindness for the subjects.
There are significant advantages to having this kind of powerful tool, especially with regards to detecting and curing diseases. However, there is also the startling implication that if a machine can replace vocations as complex and important as those in the medical profession, just how much of human society can AI replace?


Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 



